Lower levels of sCD200R1 in our patients may be due to the documented reduced expression of CD200R1, but we must also consider enhanced metalloproteinases activity in psoriasis and metabolic syndromes, which increases membrane CD200R1 shedding. This evidence concerns the gene CD200R1 and psoriasis.